AcuÑa, Rosalina A.
HRN: 11-70-64 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2023
MUPIROCIN 2%, 15G (TUBE)
06/11/2023
06/18/2023
IV
2%
BID
Ulcerating Wound
Waiting Final Action
07/15/2023
CEFTAZIDIME 1GM (VIAL)
07/15/2023
07/22/2023
IV
1gm
Q8
Sepsis
Waiting Final Action